← Back
Data updated: Mar 10, 2026
BIOFRONTERA
OncologyDermatology
BIOFRONTERA is a pharmaceutical company focused on Oncology, Dermatology. Key products include AMELUZ.
2000
Since
2
Drugs
-
Trials
1
Approved (2yr)
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 67%
0 drugs Phase 3: 1
Dermatology 33%
0 drugs Phase 2: 1
Pipeline Strength Pro
Loading...